A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DA / daunorubicin and cytarabine

[Related PubMed/MEDLINE]
Total Number of Papers: 13
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DA  (>> Co-occurring Abbreviation)
Long Form:   daunorubicin and cytarabine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia. AML, GO, LICs, PDX
2017 Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial. AML, CR, DAC, PALG
2016 Efficacy of Compound Kushen Injection in Combination with Induction Chemotherapy for Treating Adult Patients Newly Diagnosed with Acute Leukemia. AL, CKI, NK, QOL
2013 Meta-analysis of randomised clinical trials comparing idarubicin + cytarabine with daunorubicin + cytarabine as the induction chemotherapy in patients with newly diagnosed acute myeloid leukaemia. IA
2013 Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial. AML
2013 [Acute myeloid leukemia with t(11;22) (q23;q11.2): two cases report and literature review]. AML, DHA, FISH
2012 Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study. AML, DAC, DAF
2010 [Analysis of outocome of pirarubicin-based combination chemotherapy regimen in the treatment of newly diagnosed acute myeloid leukemia-a prospective, open, randomized and multicenter clinical trial]. AML, CR, TRR
2009 Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome. CR, G-CSF, HA, MDS, OS, PR, t-AML
10  2009 [Prognosis and chromosomal abnormalities in 79 children with t (8;21) acute myeloid leukemia]. AML, CR, DFS, EFS, HA, HAD, HDAC, OS
11  2002 All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. APL, ATRA, CR, DFS, OS, WBC
12  1999 [An analysis of prognostic factors for acute leukemia patients with 5-year long-term survival in Shanghai]. HA
13  1998 Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy. APL, ECOG, LBD, RA, UT